Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

📚 Prof. Tao Sun: Innovator in Oncology and Drug Development

🎓Position:

• Professor and Doctoral Supervisor, College of Pharmacy, Nankai University, China 🎓

🌟Titles and Awards:

• National Youth Talent 🌟
• Winner of the Tianjin Distinguished Youth Scholar 🏆

🔬Research Focus:

• Molecular mechanisms of malignant tumors 🧬
• Drug development 💊
• Pharmacology 🔬

📄Publications:

• Over 40 papers in prestigious journals, including Advanced Materials, Science Translational Medicine, Hepatology, and Cancer Research, as the first or corresponding author. 📄

📜Patents and Approvals:

• More than 20 authorized patents 📜
• 3 new drug clinical approvals ✅

🧪Research Leadership:

• Principal investigator of 8 major scientific research projects, including Major National Science and Technology Projects and general projects of the National Natural Science Foundation of China. 🧪

🥇Achievements in Education:

• Instructed students to win the Gold Award in the China International College Students’ “Internet+” Innovation and Entrepreneurship Competition 🥇
• Recipient of the “Top Ten Award of Scholarly Mentor and Beneficial Friend” at Nankai University 🎖
• Second Prize winner of the Nankai University Teaching Achievement Award 🥈

💊Summary:

• Prof. Tao Sun is a distinguished scholar and innovator at Nankai University, renowned for his contributions to oncology, drug development, and pharmacology. His prolific research, numerous patents, and leadership in significant scientific projects underscore his impact in the field. As an educator, he has been instrumental in guiding students to achieve excellence, earning recognition for his mentorship and teaching achievements. 🌟🔬💊

 

📊🔬Notable Publication:

 

Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

• Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
  Journal: Oncogene
• Year: 2020

 

Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1

• Authors: Cai, S., Bi, Z., Bai, Y., … Liu, H., Yang, C.
  Journal: Frontiers in Oncology
• Year: 2020

 

Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin

• Authors: Meng, J., Han, J., Wang, X., … Liu, H., Sun, T.
  Journal: Pharmacological Research
• Year: 2023

 

Correction: Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

• Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
  Journal: Oncogene
• Year: 2020

 

YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma

• Authors: Han, J., Meng, J., Chen, S., … Sun, T., Yang, C.
  Journal: Cancer Research
• Year: 2019